Radiopharmaceutical could benefit metastatic prostate cancer patients sooner
A targeted radioactive drug has moved closer to the front line of metastatic prostate cancer treatment, after a large international ...
A targeted radioactive drug has moved closer to the front line of metastatic prostate cancer treatment, after a large international ...
A groundbreaking clinical investigation has revealed a transformative approach in the management of recurrent prostate cancer presenting with limited metastatic ...
ARLINGTON, Va., June 18, 2025 — The American Society for Radiation Oncology (ASTRO), a preeminent authority in the field of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine